SAC Capital Raises Stake in Repros Therapeutics (RPRX) to 5.16%

February 20, 2013 4:39 PM EST Send to a Friend
In a 13G filing on Repros Therapeutics (NASDAQ: RPRX), Steven A. Cohen's hedge fund SAC Capital disclosed a 5.16%, or 883,207 share, stake in the company. This is up 1,489.30% from the 55,572 shares held at the end of the latest quarter ending September 30, 2012.

For more notable holders of REPROS THERAPEUTICS stock click here. For more information on SAC Capital click here.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

13Gs, Hedge Funds

Related Entities

SAC Capital, Steven A. Cohen, Hedge Funds, 13G

Add Your Comment